Literature DB >> 10332640

Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders.

W Sowers1, S Golden.   

Abstract

Persons presenting with concurrent psychiatric and substance problems present unique challenges for diagnosis and for effective and rational treatment planning. This is especially true for psychiatrists attempting to prescribe pharmacologic interventions which will promote recovery from both disorders and improve function. In order to be effective in this endeavor it is important to have a clear understanding of the dynamics of addiction as well as the particular issues and struggles related to mental illness which will affect an individual's attitude toward and use of medication. This article discusses some of the common problems related to diagnostic decision making and initiation of medication in persons with co-occurring disorders. An algorithm for guiding these decisions is presented. Common misconceptions held by these individuals regarding medication, as distinguished from "drugs," are considered. Unique psychodynamic issues that may lead these persons to actively seek medication as a solution to their problems, or which may, conversely, lead them to an outright rejection of medication as a part of their recovery, are discussed. Countertransferential issues influencing the physician's approach to prescribing for this population are also considered. The article concludes with recommendations for pharmacologic approaches to address specific psychiatric syndromes which may present in this population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332640     DOI: 10.1080/02791072.1999.10471727

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence.

Authors:  Aimee L McRae-Clark; Nathaniel L Baker; Susan C Sonne; C Lindsay DeVane; Amanda Wagner; Jessica Norton
Journal:  J Subst Abuse Treat       Date:  2015-05-07

2.  Adherence to medication regimens and participation in dual-focus self-help groups.

Authors:  Stephen Magura; Alexandre B Laudet; Daneyal Mahmood; Andrew Rosenblum; Edward Knight
Journal:  Psychiatr Serv       Date:  2002-03       Impact factor: 3.084

3.  Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement.

Authors:  Abigail J Herron; John J Mariani; Martina Pavlicova; Christina M Parrinello; Krysten W Bold; Frances R Levin; Edward V Nunes; Maria A Sullivan; Wilfred N Raby; Adam Bisaga
Journal:  Drug Alcohol Depend       Date:  2012-08-22       Impact factor: 4.492

4.  Factors associated with medication adherence among psychiatric outpatients at substance abuse risk.

Authors:  Stephen Magura; Andrew Rosenblum; Chunki Fong
Journal:  Open Addict J       Date:  2011-11-11

5.  Risk factors for medication non-adherence among psychiatric patients with substance misuse histories.

Authors:  Stephen Magura; Pedro F Mateu; Andrew Rosenblum; Harlan Matusow; Chunki Fong
Journal:  Ment Health Subst Use       Date:  2014-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.